Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength
Starting soon
Conditions studied: Osteoporosis, Osteopenia
In brief
This study aims to evaluate the relationship between serum myostatin and irisin levels and bone mineral density and muscle strength in postmenopausal women. Participants will be grouped according to bone mineral density as normal, osteopenic, or osteoporotic. Serum myostatin and irisin levels will be measured, and muscle strength will be assessed using handgrip strength and the five times sit-to-stand test. The associations between biochemical and functional parameters will be analyzed.
Key facts
- Study ID
- NCT07519551
- Run by
- Kanuni Sultan Suleyman Training and Research Hospital
- People needed
- 60
- Starts
- 2026-04-03
- Expected to finish
- 2026-05-30
- Last updated by the study team
- 2026-04-09
Who can join
Age: 50 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Postmenopausal women aged between 50 and 65 years Availability of bone mineral density measurement by dual-energy X-ray absorptiometry (DEXA) Willingness to participate in the study
You may not qualify if…
- Presence of malignancy Chronic kidney disease Chronic liver disease Neuromuscular disorders Recent major surgery or trauma Use of medications affecting bone or muscle metabolism
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.